npub176…s85de on Nostr: Dexcom showed off a new CGM at CES: Stelo. But they just released G7, how are they ...
Dexcom showed off a new CGM at CES: Stelo.
But they just released G7, how are they already replacing it?
They’re not.
Stelo is based on the G7, but has a 15 day run time, has a different app that is insights-centric, is way cheaper, and is for T2D only.
Dexcom says T2D have trouble accessing CGMs due to lack of coverage so they took the G7 and changed the software enough to make it “different” and new and cheaper and T2D only.
Rather than work on just solving this problem with existing products, they’re creating new products and calling it something different.
T1D must stay with the far more expensive G7 for their pump integration, and live with 10 day run time, and hope insurance never becomes a problem.
This proves: 1) Dexcom overcharges for their sensors and they know it, 2) Abbott is putting massive pressure on them (pump integration rolling out, Dexcom’s Stelo cost program similar to Libre, etc).
#Diabetes #Dexcom #T1D #T2D #CGM #Stelo #G7
But they just released G7, how are they already replacing it?
They’re not.
Stelo is based on the G7, but has a 15 day run time, has a different app that is insights-centric, is way cheaper, and is for T2D only.
Dexcom says T2D have trouble accessing CGMs due to lack of coverage so they took the G7 and changed the software enough to make it “different” and new and cheaper and T2D only.
Rather than work on just solving this problem with existing products, they’re creating new products and calling it something different.
T1D must stay with the far more expensive G7 for their pump integration, and live with 10 day run time, and hope insurance never becomes a problem.
This proves: 1) Dexcom overcharges for their sensors and they know it, 2) Abbott is putting massive pressure on them (pump integration rolling out, Dexcom’s Stelo cost program similar to Libre, etc).
#Diabetes #Dexcom #T1D #T2D #CGM #Stelo #G7